Effectiveness of sibutramine
The Journal of Family Practice. 2002 October;51(10):863-871
October 1, 2002|Family Medicine
Author and Disclosure Information
Given the known problems with other anorexiant drugs (eg, fenfluramine and dexfenfluramine) and the expense of sibutramine, clinicians should demand evidence of true clinical benefit and long-term safety before routinely prescribing sibutramine for treating obesity.
Eric A. Jackson, PharmD
J. Herbert Stevenson, MD
Thomas Trojian, MD
University of Connecticut School of Medicine and
Saint Francis Hospital and Medical Center
Hartford, Connecticut
E-mail: ejackson2@stfranciscare.org
